177 related articles for article (PubMed ID: 25007865)
1. Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
Woodcock A; Lötvall J; Busse WW; Bateman ED; Stone S; Ellsworth A; Jacques L
BMC Pulm Med; 2014 Jul; 14():113. PubMed ID: 25007865
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
O'Byrne PM; Woodcock A; Bleecker ER; Bateman ED; Lötvall J; Forth R; Medley H; Jacques L; Busse WW
Respir Res; 2014 Aug; 15(1):88. PubMed ID: 25108545
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
Woodcock A; Bleecker ER; Busse WW; Lötvall J; Snowise NG; Frith L; Jacques L; Haumann B; Bateman ED
Respir Res; 2011 Dec; 12(1):160. PubMed ID: 22188590
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
[TBL] [Abstract][Full Text] [Related]
6. Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.
Busse WW; Bateman ED; O'Byrne PM; Lötvall J; Woodcock A; Medley H; Forth R; Jacques L
Allergy; 2014 Nov; 69(11):1522-30. PubMed ID: 25040613
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
Lin J; Kang J; Lee SH; Wang C; Zhou X; Crawford J; Jacques L; Stone S
Respir Med; 2015 Jan; 109(1):44-53. PubMed ID: 25524507
[TBL] [Abstract][Full Text] [Related]
8. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
Bleecker ER; Bateman ED; Busse WW; Woodcock A; Frith L; House KW; Jacques L; Davis AM; Haumann B; Lötvall J
Ann Allergy Asthma Immunol; 2012 Nov; 109(5):353-358.e4. PubMed ID: 23062392
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
Busse WW; Bleecker ER; Bateman ED; Lötvall J; Forth R; Davis AM; Jacques L; Haumann B; Woodcock A
Thorax; 2012 Jan; 67(1):35-41. PubMed ID: 21828231
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist.
Lin J; Tang H; Chen P; Wang H; Kim MK; Crawford J; Jacques L; Stone S
Allergy Asthma Proc; 2016 Jul; 37(4):302-10. PubMed ID: 27401316
[TBL] [Abstract][Full Text] [Related]
11. Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
O'Byrne PM; Bleecker ER; Bateman ED; Busse WW; Woodcock A; Forth R; Toler WT; Jacques L; Lötvall J
Eur Respir J; 2014 Mar; 43(3):773-82. PubMed ID: 24136330
[TBL] [Abstract][Full Text] [Related]
12. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
Bernstein D; Andersen L; Forth R; Jacques L; Yates L
J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
[TBL] [Abstract][Full Text] [Related]
13. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
Bateman ED; Bleecker ER; Lötvall J; Woodcock A; Forth R; Medley H; Davis AM; Jacques L; Haumann B; Busse WW
Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
[TBL] [Abstract][Full Text] [Related]
14. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.
Bateman ED; O'Byrne PM; Busse WW; Lötvall J; Bleecker ER; Andersen L; Jacques L; Frith L; Lim J; Woodcock A
Thorax; 2014 Apr; 69(4):312-9. PubMed ID: 24253831
[TBL] [Abstract][Full Text] [Related]
15. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
16. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN; Krüll M; Gessner C; Gon Y; Noga O; Richard A; de Los Reyes A; Shu X; Pethe A; Tanase AM; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
[TBL] [Abstract][Full Text] [Related]
17. The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.
Lee LA; Yang S; Kerwin E; Trivedi R; Edwards LD; Pascoe S
Respir Med; 2015 Jan; 109(1):54-62. PubMed ID: 25452139
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
Lötvall J; Bleecker ER; Busse WW; O'Byrne PM; Woodcock A; Kerwin EM; Stone S; Forth R; Jacques L; Bateman ED
Respir Med; 2014 Jan; 108(1):41-9. PubMed ID: 24295556
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.
Kempsford RD; Bal J; Baines A; Renaux J; Ravindranath R; Thomas PS
Respir Med; 2016 Mar; 112():18-24. PubMed ID: 26823210
[TBL] [Abstract][Full Text] [Related]
20. Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.
Woodcock A; Bateman ED; Busse WW; Lötvall J; Snowise NG; Forth R; Jacques L; Haumann B; Bleecker ER
Respir Res; 2011 Oct; 12(1):132. PubMed ID: 21977941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
